Possible role of higher serum level of myoglobin as predictor of worse prognosis in Sars-Cov 2 hospitalized patients. A monocentric retrospective study.

Cinzia Rotondo Addolorata Corrado Ripalta Colia Nicola Maruotti Stefania Sciacca Lucia Lops Daniela Cici Angiola MeleAntonello TrottaDonato Lacedonia Maria Pia Foschino Barbaro Francesco Paolo Cantatore

Published in: Postgraduate medicine (2021)

Our results suggest that higher serum levels of myoglobin could be a considerable and effective predictor of poor outcomes in COVID-19 patients; a careful follow-up in these patients is strongly suggested. The possibility of enhancing these findings in other cohorts of COVID-19 patients could validate the clinical value of myoglobin as a biomarker for worse prognosis in COVID-19.

Keyphrases

sars cov
respiratory syndrome coronavirus
end stage renal disease
ejection fraction
newly diagnosed
coronavirus disease
prognostic factors
type diabetes
adipose tissue